Can a six‑month‑old infant safely take polyethylene glycol 3350 (Miralax)?

Can a 6-Month-Old Take Miralax?

Yes, a 6-month-old infant can safely take polyethylene glycol 3350 (Miralax) for functional constipation, though it is not FDA-approved for this age group.

FDA Approval Status and Off-Label Use

• The FDA has not established safety and effectiveness of polyethylene glycol 3350 (PEG 3350) in pediatric patients, meaning there is no official approval for use in infants 1
• Despite lack of FDA approval, multiple high-quality pediatric studies demonstrate that PEG 3350 is safe and effective in infants as young as 1 month of age 2, 3

Evidence-Based Dosing for Infants 6 Months and Older

The recommended starting dose for a 6-month-old is approximately 0.8–1.0 g/kg/day, mixed in 4–8 ounces of liquid 2, 4, 3. This translates to roughly:

• For an average 7–8 kg infant: 6–8 grams daily (approximately 1 capful of the standard powder)
• Adjust the dose every 2–3 days to achieve 1–2 soft, painless stools per day 4, 3

The effective maintenance dose in infants under 18 months averages 0.78 g/kg/day (range 0.26–1.26 g/kg/day) 2.

Safety Profile in Infants

Research specifically examining infants under 18 months found:

• 97.6% efficacy rate in relieving constipation 2
• Minimal adverse effects: transient diarrhea in 4 patients and increased gas in 1 patient, both resolving with dose adjustment 2
• No serious adverse events reported in studies of 75 infants under 2 years treated for an average of 11 months 3
• PEG 3350 is well-tolerated, palatable, and non-addictive in this age group 4, 3

Administration Instructions

• Always dissolve the powder completely in 4–8 ounces of water, juice, formula, or breast milk before giving to the infant 1
• The powder is tasteless and mixes easily with any liquid 5
• May take 2–4 days to produce the first bowel movement 1

Important Clinical Considerations

When PEG 3350 Is Appropriate:

• Functional constipation (hard, infrequent stools causing distress)
• After ruling out metabolic, endocrine, neurogenic, or structural causes 1
• When dietary modifications (adequate fluid intake, age-appropriate fiber) have been insufficient 1

Monitoring and Follow-Up:

• Parents should track stool frequency, consistency, and any adverse effects in a diary 4
• If diarrhea occurs, reduce the dose immediately—do not discontinue 2, 3
• Re-evaluate if no improvement after 2 weeks or if symptoms worsen 1

Critical Pitfall to Avoid:

Do not use PEG 3350 for more than 2 weeks without physician supervision, as prolonged use may result in electrolyte imbalance and laxative dependence 1. However, research shows that infants have been safely treated for up to 21 months under medical supervision 2.

Comparison with Adult Guidelines

While the 2023 AGA/ACG guidelines strongly recommend PEG for chronic idiopathic constipation in adults 6, these recommendations do not extend to infants. The pediatric evidence base is separate and relies on smaller studies demonstrating safety in children under 2 years 2, 3.

Special Populations

• Infants under 6 months: Limited data exist for infants 0–5 months, though one study included 3 infants in this age range with successful outcomes 2
• Premature infants: No specific data available; use with extreme caution and specialist consultation
• Infants with suspected bowel obstruction or structural abnormalities: PEG 3350 is contraindicated until structural examination of the colon is performed 1